Report Detail
Global Bacterial Conjunctivitis Drugs Market Professional Survey Report 2019
- RnM3800315 |
- 03 October, 2019 |
- Global |
- 104 Pages |
- QYResearch |
- Pharma & Healthcare
Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis is one of the most commonly observed eye problems across all age groups, generally caused by bacteria such as Staphylococcus aureus, Moraxella lacunata, Haemophilus influenza, and others (e.g. Chlamydia trachomatis, Proteus mirabilis, etc.).
The development of multi-drug resistant variants, which is resulting in the augmented use of drugs, is expected to boost market growth during the forecast period. Microbes such as Streptococcus or Staphylococcus are responsible for bacterial conjunctivitis. These microbes change themselves chemically to develop resistance to the drugs. Since this resistance develops due to the irrational use of antibiotics, it may lead to severe complications in the body of the patients. Patients are thus expected to take up more medications such as corticosteroids and higher doses of antibiotics for the treatment of such diseases. This augmented use of drugs like corticosteroids and antibiotics for the treatment of bacterial conjunctivitis will propel the prospects for growth in this market.
The growing genericization of antibacterial drugs has impacted the demand for branded drugs significantly. The generic versions of patented formulations, with almost same efficiency as the latter, are easily available at much lower rates in the market. This has increased the sales volume, albeit at the cost of revenues. Many branded ophthalmic drug manufacturers have incurred huge losses due to the generic cannibalization in this market.
The rising prevalence of multi-drug resistant organisms (MDROs), triggered by wide usage of antibiotics, incorrect drug dosage, and inappropriate medications, has created serious challenges for the treatment of infections such as bacterial conjunctivitis. Researchers across the world are working on discovering efficient drugs for these MDROs. However, the non-availability of effective medications in near future is likely to hamper the market’s growth over the coming years.
The global Bacterial Conjunctivitis Drugs market was valued at 430 million US$ in 2018 and will reach 320 million US$ by the end of 2025, growing at a CAGR of -3.7% during 2019-2025.
This report focuses on Bacterial Conjunctivitis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bacterial Conjunctivitis Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bacterial Conjunctivitis Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bacterial Conjunctivitis Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Santen Pharmaceutical
Perrigo
Merck
Bayer
Akorn
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Fluoroquinolones
Aminoglycosides
Macrolides
Others
Segment by Application
Infective (Viral and Bacterial)
Allergic
Irritant (Chemical)
Table of Contents
Executive Summary
1 Industry Overview of Bacterial Conjunctivitis Drugs
- 1.1 Definition of Bacterial Conjunctivitis Drugs
- 1.2 Bacterial Conjunctivitis Drugs Segment by Type
- 1.2.1 Global Bacterial Conjunctivitis Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Fluoroquinolones
- 1.2.3 Aminoglycosides
- 1.2.4 Macrolides
- 1.2.5 Others
- 1.3 Bacterial Conjunctivitis Drugs Segment by Applications
- 1.3.1 Global Bacterial Conjunctivitis Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Infective (Viral and Bacterial)
- 1.3.3 Allergic
- 1.3.4 Irritant (Chemical)
- 1.4 Global Bacterial Conjunctivitis Drugs Overall Market
- 1.4.1 Global Bacterial Conjunctivitis Drugs Revenue (2014-2025)
- 1.4.2 Global Bacterial Conjunctivitis Drugs Production (2014-2025)
- 1.4.3 North America Bacterial Conjunctivitis Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Bacterial Conjunctivitis Drugs Status and Prospect (2014-2025)
- 1.4.5 China Bacterial Conjunctivitis Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Bacterial Conjunctivitis Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Bacterial Conjunctivitis Drugs Status and Prospect (2014-2025)
- 1.4.8 India Bacterial Conjunctivitis Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Bacterial Conjunctivitis Drugs
- 2.3 Manufacturing Process Analysis of Bacterial Conjunctivitis Drugs
- 2.4 Industry Chain Structure of Bacterial Conjunctivitis Drugs
3 Development and Manufacturing Plants Analysis of Bacterial Conjunctivitis Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Bacterial Conjunctivitis Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Bacterial Conjunctivitis Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Bacterial Conjunctivitis Drugs Production and Capacity Analysis
- 4.2 Bacterial Conjunctivitis Drugs Revenue Analysis
- 4.3 Bacterial Conjunctivitis Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Bacterial Conjunctivitis Drugs Regional Market Analysis
- 5.1 Bacterial Conjunctivitis Drugs Production by Regions
- 5.1.1 Global Bacterial Conjunctivitis Drugs Production by Regions
- 5.1.2 Global Bacterial Conjunctivitis Drugs Revenue by Regions
- 5.2 Bacterial Conjunctivitis Drugs Consumption by Regions
- 5.3 North America Bacterial Conjunctivitis Drugs Market Analysis
- 5.3.1 North America Bacterial Conjunctivitis Drugs Production
- 5.3.2 North America Bacterial Conjunctivitis Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Bacterial Conjunctivitis Drugs Import and Export
- 5.4 Europe Bacterial Conjunctivitis Drugs Market Analysis
- 5.4.1 Europe Bacterial Conjunctivitis Drugs Production
- 5.4.2 Europe Bacterial Conjunctivitis Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Bacterial Conjunctivitis Drugs Import and Export
- 5.5 China Bacterial Conjunctivitis Drugs Market Analysis
- 5.5.1 China Bacterial Conjunctivitis Drugs Production
- 5.5.2 China Bacterial Conjunctivitis Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Bacterial Conjunctivitis Drugs Import and Export
- 5.6 Japan Bacterial Conjunctivitis Drugs Market Analysis
- 5.6.1 Japan Bacterial Conjunctivitis Drugs Production
- 5.6.2 Japan Bacterial Conjunctivitis Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Bacterial Conjunctivitis Drugs Import and Export
- 5.7 Southeast Asia Bacterial Conjunctivitis Drugs Market Analysis
- 5.7.1 Southeast Asia Bacterial Conjunctivitis Drugs Production
- 5.7.2 Southeast Asia Bacterial Conjunctivitis Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Bacterial Conjunctivitis Drugs Import and Export
- 5.8 India Bacterial Conjunctivitis Drugs Market Analysis
- 5.8.1 India Bacterial Conjunctivitis Drugs Production
- 5.8.2 India Bacterial Conjunctivitis Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Bacterial Conjunctivitis Drugs Import and Export
6 Bacterial Conjunctivitis Drugs Segment Market Analysis (by Type)
- 6.1 Global Bacterial Conjunctivitis Drugs Production by Type
- 6.2 Global Bacterial Conjunctivitis Drugs Revenue by Type
- 6.3 Bacterial Conjunctivitis Drugs Price by Type
7 Bacterial Conjunctivitis Drugs Segment Market Analysis (by Application)
- 7.1 Global Bacterial Conjunctivitis Drugs Consumption by Application
- 7.2 Global Bacterial Conjunctivitis Drugs Consumption Market Share by Application (2014-2019)
8 Bacterial Conjunctivitis Drugs Major Manufacturers Analysis
- 8.1 Santen Pharmaceutical
- 8.1.1 Santen Pharmaceutical Bacterial Conjunctivitis Drugs Production Sites and Area Served
- 8.1.2 Santen Pharmaceutical Product Introduction, Application and Specification
- 8.1.3 Santen Pharmaceutical Bacterial Conjunctivitis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Perrigo
- 8.2.1 Perrigo Bacterial Conjunctivitis Drugs Production Sites and Area Served
- 8.2.2 Perrigo Product Introduction, Application and Specification
- 8.2.3 Perrigo Bacterial Conjunctivitis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Merck
- 8.3.1 Merck Bacterial Conjunctivitis Drugs Production Sites and Area Served
- 8.3.2 Merck Product Introduction, Application and Specification
- 8.3.3 Merck Bacterial Conjunctivitis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Bayer
- 8.4.1 Bayer Bacterial Conjunctivitis Drugs Production Sites and Area Served
- 8.4.2 Bayer Product Introduction, Application and Specification
- 8.4.3 Bayer Bacterial Conjunctivitis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Akorn
- 8.5.1 Akorn Bacterial Conjunctivitis Drugs Production Sites and Area Served
- 8.5.2 Akorn Product Introduction, Application and Specification
- 8.5.3 Akorn Bacterial Conjunctivitis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
9 Development Trend of Analysis of Bacterial Conjunctivitis Drugs Market
- 9.1 Global Bacterial Conjunctivitis Drugs Market Trend Analysis
- 9.1.1 Global Bacterial Conjunctivitis Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Bacterial Conjunctivitis Drugs Regional Market Trend
- 9.2.1 North America Bacterial Conjunctivitis Drugs Forecast 2019-2025
- 9.2.2 Europe Bacterial Conjunctivitis Drugs Forecast 2019-2025
- 9.2.3 China Bacterial Conjunctivitis Drugs Forecast 2019-2025
- 9.2.4 Japan Bacterial Conjunctivitis Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Bacterial Conjunctivitis Drugs Forecast 2019-2025
- 9.2.6 India Bacterial Conjunctivitis Drugs Forecast 2019-2025
- 9.3 Bacterial Conjunctivitis Drugs Market Trend (Product Type)
- 9.4 Bacterial Conjunctivitis Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Bacterial Conjunctivitis Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Bacterial Conjunctivitis Drugs. Industry analysis & Market Report on Bacterial Conjunctivitis Drugs is a syndicated market report, published as Global Bacterial Conjunctivitis Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Bacterial Conjunctivitis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
